Syndrome of acquired factor X deficiency and systemic amyloidosis; in vivo studies of the metabolic fate of factor X

N Engl J Med. 1977 Jul 14;297(2):81-5. doi: 10.1056/NEJM197707142970203.

Abstract

To determine the metabolic fate of factor X in primary amyloidosis associated with factor X deficiency, we examined the pathways of its catabolism in a man with this syndrome. Intravenous infusion of human or bovine 131I-labeled factor X established a triphasic plasma clearance pattern for factor X. About 85 per cent of the factor X disappeared, with a disappearance half-time of less than 30 seconds. A second and third phase showed a T1/2 of 90 minutes and nine hours respectively. 131I-labeles factor X in plasma did not appear to be rapidly modified or degraded. Relatively minor quantities of 131I were cleared into the urine. We observed a diffuse distribution of radioactivity over the body surface, with a concentration in the hepatic and splenic regions. These studies demonstrate than factor X deficiency associated with systemic amyloidosis is due to binding of factor X to body tissue, probably within the circulatory system.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amyloidosis / blood
  • Amyloidosis / complications*
  • Amyloidosis / metabolism
  • Animals
  • Blood Coagulation Tests
  • Blood Vessels / metabolism
  • Cattle
  • Factor X / administration & dosage
  • Factor X / metabolism*
  • Factor X / therapeutic use
  • Factor X / urine
  • Factor X Deficiency / complications*
  • Factor X Deficiency / metabolism
  • Factor X Deficiency / therapy
  • Humans
  • Hypoprothrombinemias / complications*
  • Iodine Radioisotopes
  • Male
  • Middle Aged
  • Rabbits
  • Syndrome
  • Time Factors

Substances

  • Iodine Radioisotopes
  • Factor X